Table:
begin	end	state
1	26	cytoplasmic
27	45	transmembrane
46	61	non-cytoplasmic
62	85	transmembrane
86	96	cytoplasmic
97	116	transmembrane
117	121	non-cytoplasmic
122	143	transmembrane
144	159	cytoplasmic
160	185	transmembrane
186	190	non-cytoplasmic
191	210	transmembrane
211	259	cytoplasmic
260	278	transmembrane
279	297	non-cytoplasmic
298	318	transmembrane
319	326	cytoplasmic
327	345	transmembrane
346	351	non-cytoplasmic
352	379	transmembrane
380	391	cytoplasmic
392	411	transmembrane
412	422	non-cytoplasmic
423	446	transmembrane
447	463	cytoplasmic

Input:
>17726 FitnessBrowser__Keio:17726
MLAFLNQVRKPTLDLPLEVRRKMWFKPFMQSYLVVFIGYLTMYLIRKNFNIAQNDMISTY
GLSMTQLGMIGLGFSITYGVGKTLVSYYADGKNTKQFLPFMLILSAICMLGFSASMGSGS
VSLFLMIAFYALSGFFQSTGGSCSYSTITKWTPRRKRGTFLGFWNISHNLGGAGAAGVAL
FGANYLFDGHVIGMFIFPSIIALIVGFIGLRYGSDSPESYGLGKAEELFGEEISEEDKET
ESTDMTKWQIFVEYVLKNKVIWLLCFANIFLYVVRIGIDQWSTVYAFQELKLSKAVAIQG
FTLFEAGALVGTLLWGWLSDLANGRRGLVACIALALIIATLGVYQHASNEYIYLASLFAL
GFLVFGPQLLIGVAAVGFVPKKAIGAADGIKGTFAYLIGDSFAKLGLGMIADGTPVFGLT
GWAGTFAALDIAAIGCICLMAIVAVMEERKIRREKKIQQLTVA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server